ARCHIVES

Study Finds Up To 12 Percent Of Specimens Misdiagnosed

This article is from The Cancer Letter archive.

Vol. 28 No. 10 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

NIH Director Zerhouni to discuss Roadmap initiatives Feb. 27.

February 20, 2004

MRI Effective For Women With BRCA Gene Mutations

September 24, 2004

FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate.

May 28, 2004

In Brief: Reagan Names David Korn New Chairman Of NCAB; Consensus Conference On Limb Sparing Planned

June 22, 1984

Steven Woolf: Why CMS Should Not Cover LDCT

May 9, 2014

In Brief: DeVita Says He’ll Go Along With Any NCAB Decision On Organ Site Program; Talbt New AACI President

February 26, 1982